Posts Tagged ‘HTZ’

Hertz Investors Hurting As Stock Tumbles On Revised Annual Forecast

HTZ – Hertz Global Holdings Inc. – Investors in car rental company Hertz Global Holdings Inc. are taking it on the chin today, with shares in the name sliding as much as 13% in the early going to a three-month low of $22.47. Shares fell after Hertz lowered its full year 2013 earnings and revenue guidance, primarily due to weaker than expected U.S. airport car rentals, according to a press release issued by the company.  

October expiry put options changing hands on the stock this morning indicates one or more traders are bracing for shares in the name to weaken further in the near term. Around 2,000 of the Oct $23 strike puts appear to have been purchased, most of the contracts at a premium of $1.00 each. Put buyers make money at expiration next month if shares in HTZ decline 2.0% from today’s low of $22.47 to breach the breakeven point on the downside at $22.00. Shares in Hertz last traded below $22.00 in April. 

CAG – ConAgra Foods, Inc. – Shares in the provider of Chef Boyardee, Hunt’s and other branded consumer food products are in negative territory on Thursday morning, off 0.25% at $30.37 as of 10:45 a.m. ET. The stock has been hit hard in recent weeks, currently down more than 18% from a multi-year high of $37.28 reached at the beginning of August.

Trading in ConAgra call options this morning, however, suggests some strategists may be positioning for the price of the underlying to rebound during the final months of 2013. The most traded options contracts on CAG thus far in the session are the Dec $32 strike calls, with volume topping 5,500 contracts versus open interest of 1,615 contracts. Time and sales data suggests most of the volume was purchased within 15 minutes of the opening bell at a premium of $0.55 each. Call buyers may profit at December expiration in the event that ConAgra’s shares rally 7.0% over the current price of $30.28 to exceed the breakeven point at $32.55. 


Tags: ,




Bullish Positions Take Shape Ahead Of Walgreen Co. Earnings

Today’s tickers: WAG, IO, HTZ & NBR

WAG - Walgreen Co. – Shares in the largest U.S. drugstore chain may rally sharply heading into the New Year, according to one options player dabbling in Jan. 2012 contract call options this morning. The buyer of a sizable bull call spread may be using the position to prepare for Walgreen’s shares to pop after the company reports first-quarter earnings ahead of the opening bell on December 21. The stock currently trades flat on the session at $34.01 as of 11:45 AM in New York. It looks like the trader purchased a roughly-3,000 lot Jan. 2012 $35/$39 call spread for an average net premium of $1.06 per contract. The investor stands ready to profit at expiration next year as long as shares in Walgreen Co. increase 6.0% to exceed the average breakeven price of $36.06. Maximum potential profits of $ are available to the call-spreader if the drug retailer’s shares soar 14.7% to trade above $39.00 at expiration in January. Walgreen’s shares last traded above $39.00 at the beginning of August.

IO - ION Geophysical Corp. – The provider of seismic solutions and equipment to the global energy industry rallied in sympathy with shares in Mitcham Industries (MIND), which jumped to a new 52-week high today after reporting better-than-expected third-quarter earnings after the close on Tuesday. ION’s shares are up 1.8% to stand at $6.82 as of 12:20 PM in New York. At least one options trader is taking advantage of the positive day for ION’s shares by picking up bearish put options on the cheap. It looks like the investor purchased more than 3,000 puts at the Dec. $6.0 strike for a premium of $0.10 each. These same options would have cost the trader $0.50 each less than one week ago. The bearish position may yield profits…
continue reading


Tags: , , ,




Bullish Player Takes Profits, Injects Fresh Optimism in Sanofi-Aventis Options

Today’s tickers: SNY, DELL, HTZ & GT

SNY - Sanofi-Aventis – The French drug manufacturer popped up on our ‘hot by options volume’ market scanner this morning after one strategist extended bullish sentiment on the stock. Shares in Sanofi-Aventis rallied earlier in the session, but currently stand 0.35% lower on the day at $39.55 as of 11:30am in New York. The vaccines division of the pharmaceutical company, Sanofi Pasteur, said today it has received approval from the U.S. Food & Drug Administration (FDA) for its intradermal microinjection delivery system of its influenza vaccine, Fluzone. The vaccine was previously approved for intramuscular administration, but Sanofi said it plans to have the Fluzone Intradermal vaccine available to U.S. healthcare providers in time for the 2011-2012 influenza season. The bullish options trader responsible for nearly all of the day’s volume appears to be taking profits off the table on a previously established long call position. It looks like the investor originally purchased 2,000 calls at the May $37 strike for an average premium of $1.025 back on April 14 when shares in SNY were hovering around $37.54. Since the calls were purchased, shares in Sanofi rallied as much as 8.6% to touch a new 52-week high of $40.75 last Wednesday. Although shares are currently off last week’s high, the bullish trader was still able to rake in substantial profits on the long calls stance, selling all 2,000 of the May $37 strike calls this morning at a premium of $2.45 apiece. Net profits on the sale amount to $1.425 per contract. Next, the trader extended bullish sentiment on the drug maker, buying 2,000 fresh calls out at the June $40 strike for a premium of $0.40 per contract. The investor profits on the new batch of call options if shares in SNY increase 2.15% over the current price of $39.55 to surpass the effective breakeven point to the upside at $40.40 by expiration in June.…
continue reading


Tags: , , ,




Hartford Financial Services Group Call Options in High Demand

Today’s tickers: HIG, EW, GENZ, AWK, STEC, DELL, HTZ, DBRN & OVTI

HIGHartford Financial Services Group, Inc.Call options on the insurance and financial services firm are flying off the shelves today with shares trading higher by as much as 2.95% to tie down an intraday high of $22.99. As of 2:20 pm ET, more than 14.1 calls have changed hands on HIG for each single put option in action on the stock thus far in the session. The sharp increase in demand for calls bumped up the insurer’s overall reading of options implied volatility 26.4% to today’s high of 56.57%. While some investors populating HIG are selling calls, the majority of calls traded were purchased by traders positioning for continue appreciation in the price of the underlying shares. Near-term optimists picked up roughly 7,500 calls at the September $23 strike for an average premium of $0.50 each. Call buyers at this strike make money if HIG’s shares rally above the average breakeven price of $23.50 by expiration day next Friday. Other bulls purchased some 4,600 calls at the September $24 strike for premium of $0.23 each. Another 2,800 calls were scooped up at the higher September $25 strike at an average premium of $0.16 a-pop. More than 10,800 calls changed hands at the September $26 strike versus previously existing open interest of just 3,300 lots. The vast majority of those calls, some 7,000 contracts, traded to the middle of the market at a premium of $0.12 apiece. Bullish sentiment on the insurance company spread to the October $24 strike where some 2,000 calls were coveted at an average premium of $0.76 each. Investors holding these contracts stand ready to accumulate profits if HIG’s shares jump 7.7% over today’s high of $22.99 to exceed the average breakeven price of $24.76 by October expiration. An additional 2,000 calls were picked up at the October $25 strike for premium of $0.70 a-pop. Traders long the calls make money if shares surge 11.8% to trade above $25.70 ahead of expiration day next month. Options traders exchanged more than 66,700 contracts on Hartford Financial Services Group by 2:30 pm ET.

EW – Edwards Life Sciences Corp. – The provider of products and technologies created to treat advanced cardiovascular disease popped up on our ‘hot by options volume’ market scanner after…
continue reading


Tags: , , , , , , , ,




Kaleidoscope of Butterflies Lie in Wait for Goldman Sachs Rebound

Today’s tickers: GS, BAC, AEA, QDEL, DUK, HTZ, EFA, MAR, PXD & WLP

GS – Goldman Sachs Group, Inc. – Bullish options strategists touting butterfly wings were once again enticed by the sweet nectar of potential profits hinging on Goldman Sachs’ shares ability to continue to climb out of the hole created by the drama and uncertainty surrounding the SEC’s suit against the investment banking firm. Goldman’s shares are up 2.36% in late afternoon trading at $156.65, but the stock realized a 4.9% rebound in its shares from Tuesday’s intraday low of $150.15, to an intraday high of $157.45 during the current session. We observed bullish butterfly plays on Goldman Sachs each day this week suggesting investors are pre-ordering their tickets on the rebound-boat so as not to miss out on profits to the upside. Tuesday’s call-fly engaged the October 160/175/190 strikes while Monday’s butterfly spread involved the May 150/160/170 strikes. Today, butterflies parked themselves in the June contract, buying approximately 8,000 calls at the June $165 strike for a premium of $4.66 each [wing 1] and purchasing roughly 8,000 calls at the higher June $185 strike for $0.88 apiece [wing 2]. The body of the butterfly centered at the June $175 strike where some 16,000 calls were shed for an average premium of $1.99 a-pop. Average net premium paid for the spread amounts to just $1.56 per contract. The investor or investors holding the bullish stance stand ready to accrue maximum potential profits of $8.44 per contract should GS shares surge up to $175.00 by expiration day. The transaction is a very efficient way to act on bullish sentiment because maximum loss potential – $1.56 per contract in this case – is scant when compared to potential profits which are 5.4 times greater. Profits start to amass if Goldman’s shares rally 6.33% from the current price of $156.65 to breach the average breakeven price of $166.56 ahead of June expiration. Finally, not all optimistic options players selected the butterfly spread strategy. A long-term bullish trader targeted the October contract to enact a plain-vanilla debit call spread. The investor picked up 3,000 in-the-money calls at the October $155 strike for a hefty average premium of $16.50 apiece, and sold the same number of calls at the higher October $180 strike for $6.55 each. The net cost of the call spread amounts to $9.95 per contract, and yields maximum potential profits…
continue reading


Tags: , , , , , , , , ,




Mega Earnings Monday – 1,000 Reports This Week!

What a crazy week this is going to be!

Pre-Market we're hearing from BLK, CAT (are we building stuff?), EXP, HTZ, HUM, LO, TUES and TZOO and later we will hear from BSX, CHH, OLN, RSH, RCII, TXN (major) and my "friendbuddypal" Cramer's TSCM (if they are not delayed).  Revenues at The Street have crept back up this year in a recovery that pretty much mirrors the market.  The company does pay a nice 2.6% dividend, which works out to a nice $200,000 bonus on Jimmy's 2.1M shares (6.7% of the company) so you know that bonus will be a priority for the company.  Cramer was BUYBUYBUYing his own stock at $2.41 in January but sadly they have no options to hedge…  They might make a nice pick-up after earnings if they disappoint and head back to $3 or less.

I'm full of useful information on hundreds of stocks right now because I've been researching our new Buy List but I'm not pleased with what I've been seeing so far and this week's tidal wave of earnings, with 1,000 companies reporting means we're in no hurry to dip our toes in the water.  I told Members this morning I should probably be working on a Sell List, as it's much easier to find companies I want to short than ones I want to buy.  Even in the Weekly Wrap-Up, we featured a 1,900% downside hedge on the Russell to offset the 566% plays and other bullish plays we've begun to reluctantly take, just so we don't feel too silly in this runaway market. 

If you have never watched Jim Cramer discussing the sleazy, manipulative ways he used to game the markets – you really must take 10 minutes and watch this video, where Jim explains how any immoral bastard with $10M can yank the entire futures market around at will.  He prefaces one of his favorite strategies with "this is blatantly illegal but.. I think it's really important… these are things you MUST do on a day like today and if you are not doing it, maybe you shouldn't be in the game."  Are you playing the game or are you being played? 

The biggest game ever played may be unwinding as we speak.  Bloomberg reports that foreign-exchange profits from carry trades are disappearing as differences in central
continue reading


Tags: , , , , , , , , , , , , , , , , , , ,




 
 
 

Phil's Favorites

Coronavirus and cancer hijack the same parts in human cells to spread - and our team identified existing cancer drugs that could fight COVID-19

 

Coronavirus and cancer hijack the same parts in human cells to spread – and our team identified existing cancer drugs that could fight COVID-19

SARS-CoV-2 turns on a cellular switch to build the tubes in this photo – called filopodia – that might help viral particles – the little spheres – spread more easily. Dr Elizabeth Fischer, NIAID NIH / Bouhaddou et al. Elsevier 2020, CC BY-ND

Courtesy of Nevan Krogan, University of California, San Francisco

Most antivirals in use today ...



more from Ilene

Biotech/COVID-19

Coronavirus and cancer hijack the same parts in human cells to spread - and our team identified existing cancer drugs that could fight COVID-19

 

Coronavirus and cancer hijack the same parts in human cells to spread – and our team identified existing cancer drugs that could fight COVID-19

SARS-CoV-2 turns on a cellular switch to build the tubes in this photo – called filopodia – that might help viral particles – the little spheres – spread more easily. Dr Elizabeth Fischer, NIAID NIH / Bouhaddou et al. Elsevier 2020, CC BY-ND

Courtesy of Nevan Krogan, University of California, San Francisco

Most antivirals in use today ...



more from Biotech/COVID-19

ValueWalk

The M&A Activism Picture Is Not All Rosy

By ActivistInsight. Originally published at ValueWalk.

This week we released Shareholder activism in H1 2020 – the definitive statistical report on an unprecedented proxy season.

Q2 2020 hedge fund letters, conferences and more

Given just how massive and longlasting the impact of the coronavirus pandemic has been, including an end to the longest bull market in history (followed after the briefest of pauses by a roaring recovery), an end to the ...



more from ValueWalk

Zero Hedge

US Suffers Record 52k New COVID-19 Cases As Holiday Weekend Begins: Live Updates

Courtesy of ZeroHedge View original post here.

Coronavirus cases in the US hit another daily record on Thursday as Americans prepared for a distinctly joyless Fourth of July weekend that bears none of the sense of joy and revival that the country enjoyed on Memorial Day Weekend. According to JHU, the US reported 52,291 new cases, bringing its nationwide total to 2,739,879.

Source: JHU ...



more from Tyler

The Technical Traders

Wild Volatility Continues As US Markets Attempt To Establish New Trend

Courtesy of Technical Traders

We’ve continued to attempt to warn investors of the risks ahead for the US and global markets by generating these research posts and by providing very clear data supporting our conclusions.  Throughout the entire months of May and June, we’ve seen various economic data points report very mixed results – and in some cases, surprise numbers as a result of the deep economic collapse related to the COVID-19 virus event.  This research post should help to clear things up going forward for most traders/investors.

As technical traders, we attempt to digest these economic data factors into technical and price analysis while determining where and what ...



more from Tech. Traders

Kimble Charting Solutions

Nasdaq 100 Relative Strength Testing 2000 Highs

Courtesy of Chris Kimble

The tech bubble didn’t end well. BUT it did tell us that the world was shifting into the technology age…

Since the Nasdaq 100 bottomed in 2002, the broader markets have turned over leadership to the technology sector.

This can be seen in today’s chart, highlighting the ratio of Nasdaq 100 to S&P 500 performance (on a “monthly” basis).

As you can see, the bars are in a rising bullish channel and have turned sharply higher since the 2018 stock market lows. This highlights the strength of the Nasdaq 100 and large-cap tech stocks.

...

more from Kimble C.S.

Chart School

US Dollar with Ney and Gann Angles

Courtesy of Read the Ticker

Where is price going, is there strength or weakness in the chart?


Previous Post on the US Dollar : Where is the US Dollar trend headed ?


The question is always what will the future price action look like ?


This post will highlight the use of lines generated by angles. Not trend lines, as trend lines require two known points on a chart, where as angles require only one known point and a angle degree to draw a line. The question then becomes how is the angle degree determined.



There are two theories: ...

more from Chart School

Lee's Free Thinking

These Charts Show COVID 19 Is Spreading in the US and Will Kill the Economy

 

These Charts Show COVID 19 Is Spreading in the US and Will Kill the Economy

Courtesy of  

The COVID 19 pandemic is, predictably, worsening again in much of the US. Only the Northeast, and to a lesser extent some Midwestern states, have been consistently improving. And that trend could also reverse as those states fully reopen.

The problem in the US seems to be widespread public resistance to recommended practices of social distancing and mask wearing. In countries where these practices have been practi...



more from Lee

Digital Currencies

Blockchains can trace foods from farm to plate, but the industry is still behind the curve

 

Blockchains can trace foods from farm to plate, but the industry is still behind the curve

App-etising? LDprod

Courtesy of Michael Rogerson, University of Bath and Glenn Parry, University of Surrey

Food supply chains were vulnerable long before the coronavirus pandemic. Recent scandals have ranged from modern slavery ...



more from Bitcoin

Members' Corner

Coronavirus, 'Plandemic' and the seven traits of conspiratorial thinking

 

Coronavirus, 'Plandemic' and the seven traits of conspiratorial thinking

No matter the details of the plot, conspiracy theories follow common patterns of thought. Ranta Images/iStock/Getty Images Plus

Courtesy of John Cook, George Mason University; Sander van der Linden, University of Cambridge; Stephan Lewandowsky...



more from Our Members

Insider Scoop

Economic Data Scheduled For Friday

Courtesy of Benzinga

  • Data on nonfarm payrolls and unemployment rate for March will be released at 8:30 a.m. ET.
  • US Services Purchasing Managers' Index for March is scheduled for release at 9:45 a.m. ET.
  • The ISM's non-manufacturing index for March will be released at 10:00 a.m. ET.
  • The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
...

http://www.insidercow.com/ more from Insider

Promotions

Free, Live Webinar on Stocks, Options and Trading Strategies

TODAY's LIVE webinar on stocks, options and trading strategy is open to all!

Feb. 26, 1pm EST

Click HERE to join the PSW weekly webinar at 1 pm EST.

Phil will discuss positions, COVID-19, market volatility -- the selloff -- and more! 

This week, we also have a special presentation from Mike Anton of TradeExchange.com. It's a new service that we're excited to be a part of! 

Mike will show off the TradeExchange's new platform which you can try for free.  

...

more from Promotions

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. Contact Ilene to learn about our affiliate and content sharing programs.